English 
 |
| We provide APIs for weight loss and diabetes treatment in different specifications, if necessary, you can contact us for more details. | |||||||||
The raw materials Semaglutide, Liraglutide and Tirzepatide are three commonly used anti-diabetic drugs and belong to the GLP-1 receptor agonist category. Their main use is to treat type 2 diabetes.
Semaglutide: A long-acting GLP-1 receptor agonist that helps lower blood sugar levels by stimulating the release of insulin and inhibiting glucagon secretion. In addition, semaglutide has also been shown to have positive effects on weight management and cardiovascular protection.
Liraglutide: A GLP-1 receptor agonist that, like semaglutide, lowers blood sugar levels, improves insulin sensitivity, and aids in weight management.
Tirzepatide: A new generation of GLP-1 receptor agonist with a dual mechanism of action. It can not only stimulate the release of insulin and inhibit the secretion of glucagon, but also inhibit insulin resistance. Tilpotide is excellent at lowering blood sugar levels and controlling weight.
These drugs have been widely used in the treatment of type 2 diabetes and also have positive effects in weight management and cardiovascular protection. We offer high-quality Semaglutide, Liraglutide and Tirzepatide APIs to support your drug manufacturing and development needs.